FDA inspection
Xiamen LP Pharmaceutical Co., Ltd.: FDA inspection ending Apr 19, 2024
FDA inspection 1239875 · Voluntary Action Indicated (VAI) · Xia Men
Key facts
| Inspection ID | 1239875 |
|---|---|
| Firm | Xiamen LP Pharmaceutical Co., Ltd. |
| FEI number | 3013002864 |
| Address | 2010 Wengjiao West Road, Haicang |
| City | Xia Men |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Apr 19, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data